Search research articles
Contact Us
Filters
Showing results (121-130 of 203) with videos related to
Page
of 21
Sort By:
American Journal of Hematology
|
October 4, 2017
High dose chemotherapy and autologous stem cell transplantation in nodular lymphocyte-predominant Hodgkin lymphoma: A retrospective study by the European society for blood and marrow transplantation-lymphoma working party
Saad Akhtar, Silvia Montoto, Ariane Boumendil, et al.
Bone Marrow Transplantation
|
December 23, 2017
Tandem autologous-haploidentical transplantation is a feasible and effective program for refractory Hodgkin lymphoma
Jacopo Mariotti, Stefania Bramanti, Raynier Devillier, et al.
Leukemia & Lymphoma
|
June 19, 2012
Poor autologous mobilization status does not impact on hematological recovery but affects outcome after allogeneic stem cell transplant for lymphoma and myeloma
Roberto Crocchiolo, Christian Chabannon, Jean El-Cheikh, et al.
Blood
|
December 15, 2011
Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation
Christoph Schmid, Myriam Labopin, Arnon Nagler, et al.
Frontiers in Immunology
|
February 11, 2022
Extracellular Vesicles as Biomarkers of Acute Graft-vs.-Host Disease After Haploidentical Stem Cell Transplantation and Post-Transplant Cyclophosphamide
Giuseppe Lia, Clara Di Vito, Stefania Bruno, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 10, 2013
Antithymocyte globulin in reduced-intensity conditioning regimen allows a high disease-free survival exempt of long-term chronic graft-versus-host disease
Raynier Devillier, Sabine Fürst, Jean El-Cheikh, et al.
Bone Marrow Transplantation
|
May 13, 2022
Impact of donor kinship on non-T-cell depleted haploidentical stem cell transplantation with post transplantation cyclophosphamide for acute leukemia: From the ALWP of the EBMT
Ivetta Danylesko, Christophe Peczynski, Myriam Labopin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 22, 2020
Nonmyeloablative Conditioning Regimen before T Cell Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Advanced Hodgkin and Non-Hodgkin Lymphomas
Catalina Montes de Oca, Luca Castagna, Chiara De Philippis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 7, 2016
Bendamustine in Combination With Gemcitabine and Vinorelbine Is an Effective Regimen As Induction Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma: Final Results of a Multicenter Phase II Study
Armando Santoro, Rita Mazza, Alessandro Pulsoni, et al.
Frontiers in Immunology
|
January 25, 2024
Persistence of KIR<sup>neg</sup> NK cells after haploidentical hematopoietic stem cell transplantation protects from human cytomegalovirus infection/reactivation
Clara Di Vito, Nicolò Coianiz, Michela Calvi, et al.
Page
of 21
Search research articles
Search
Showing results (121-130 of 203) with videos related to
Sort By:
Page
of 21
American Journal of Hematology
|
October 4, 2017
High dose chemotherapy and autologous stem cell transplantation in nodular lymphocyte-predominant Hodgkin lymphoma: A retrospective study by the European society for blood and marrow transplantation-lymphoma working party
Saad Akhtar, Silvia Montoto, Ariane Boumendil, et al.
Bone Marrow Transplantation
|
December 23, 2017
Tandem autologous-haploidentical transplantation is a feasible and effective program for refractory Hodgkin lymphoma
Jacopo Mariotti, Stefania Bramanti, Raynier Devillier, et al.
Leukemia & Lymphoma
|
June 19, 2012
Poor autologous mobilization status does not impact on hematological recovery but affects outcome after allogeneic stem cell transplant for lymphoma and myeloma
Roberto Crocchiolo, Christian Chabannon, Jean El-Cheikh, et al.
Blood
|
December 15, 2011
Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation
Christoph Schmid, Myriam Labopin, Arnon Nagler, et al.
Frontiers in Immunology
|
February 11, 2022
Extracellular Vesicles as Biomarkers of Acute Graft-vs.-Host Disease After Haploidentical Stem Cell Transplantation and Post-Transplant Cyclophosphamide
Giuseppe Lia, Clara Di Vito, Stefania Bruno, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 10, 2013
Antithymocyte globulin in reduced-intensity conditioning regimen allows a high disease-free survival exempt of long-term chronic graft-versus-host disease
Raynier Devillier, Sabine Fürst, Jean El-Cheikh, et al.
Bone Marrow Transplantation
|
May 13, 2022
Impact of donor kinship on non-T-cell depleted haploidentical stem cell transplantation with post transplantation cyclophosphamide for acute leukemia: From the ALWP of the EBMT
Ivetta Danylesko, Christophe Peczynski, Myriam Labopin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 22, 2020
Nonmyeloablative Conditioning Regimen before T Cell Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Advanced Hodgkin and Non-Hodgkin Lymphomas
Catalina Montes de Oca, Luca Castagna, Chiara De Philippis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 7, 2016
Bendamustine in Combination With Gemcitabine and Vinorelbine Is an Effective Regimen As Induction Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma: Final Results of a Multicenter Phase II Study
Armando Santoro, Rita Mazza, Alessandro Pulsoni, et al.
Frontiers in Immunology
|
January 25, 2024
Persistence of KIR<sup>neg</sup> NK cells after haploidentical hematopoietic stem cell transplantation protects from human cytomegalovirus infection/reactivation
Clara Di Vito, Nicolò Coianiz, Michela Calvi, et al.
Page
of 21